BFG
WST icon

Bleakley Financial Group’s West Pharmaceutical WST Stock Holding History

Bleakley Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Buy
+10,173
New +$3.11M 0.05% 316
2025
Q1 		– Sell
-2,170
Closed -$711K – 1028
2024
Q4 		$711K Sell
2,170
-188
-8% -$59.2K 0.02% 512
2024
Q3 		$708K Buy
2,358
+76
+3% +$23.3K 0.02% 495
2024
Q2 		$752K Buy
2,282
+108
+5% +$38.2K 0.02% 485
2024
Q1 		$860K Buy
2,174
+41
+2% +$15.2K 0.02% 468
2023
Q4 		$751K Sell
2,133
-12
-0.6% -$4.25K 0.02% 479
2023
Q3 		$805K Sell
2,145
-55
-3% -$21.3K 0.03% 423
2023
Q2 		$841K Buy
2,200
+38
+2% +$13.6K 0.03% 448
2023
Q1 		$749K Sell
2,162
-105
-5% -$30.7K 0.03% 462
2022
Q4 		$534K Buy
+2,267
New +$537K 0.02% 537

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bleakley Financial Group's WST Position: Q2 2026 in Review

Bleakley Financial Group opened a new position in West Pharmaceutical (WST) in Q2 2026: 10,173 shares worth $3.65M. The stake represents 0.05% of the portfolio and ranks #316 among its holdings. This is a return to the name: Bleakley Financial Group previously reported a position in WST as recently as Q4 2024.

Bleakley Financial Group first reported a position in WST in Q4 2022 and has held it in 10 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bleakley Financial Group held 10,173 shares of West Pharmaceutical worth $3.65M as of Q2 2026.
  • West Pharmaceutical was a new Bleakley Financial Group position in Q2 2026.
  • West Pharmaceutical made up 0.05% of Bleakley Financial Group's portfolio in Q2 2026, its #316 holding.
  • Bleakley Financial Group first reported a position in West Pharmaceutical in Q4 2022 and has held it in 10 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.